SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-061733
Filing Date
2020-12-03
Accepted
2020-12-03 21:09:04
Documents
2
Period of Report
2020-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10775
2 POA DOCUMENT poa.txt EX-24.3_948412 3097
  Complete submission text file 0001209191-20-061733.txt   15270
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Issuer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SILVERBACK THERAPEUTICS, INC. 500 FAIRVIEW AVENUE N, SUITE 600 SEATTLE WA 98109
Business Address
Odegard Valerie (Reporting) CIK: 0001832432 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39756 | Film No.: 201368434